Anti-WFDC9/ WAP9/ dJ688G8.2 functional antibody

Anti-WFDC9/ WAP9/ dJ688G8.2 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to WFDC9/WFDC9 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0553-Ab-1/ GM-Tg-hg-SE0553-Ab-2Anti-Human WFDC9 monoclonal antibodyHuman
GM-Tg-rg-SE0553-Ab-1/ GM-Tg-rg-SE0553-Ab-2Anti-Rat WFDC9 monoclonal antibodyRat
GM-Tg-mg-SE0553-Ab-1/ GM-Tg-mg-SE0553-Ab-2Anti-Mouse WFDC9 monoclonal antibodyMouse
GM-Tg-cynog-SE0553-Ab-1/ GM-Tg-cynog-SE0553-Ab-2Anti-Cynomolgus/ Rhesus macaque WFDC9 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0553-Ab-1/ GM-Tg-felg-SE0553-Ab-2Anti-Feline WFDC9 monoclonal antibodyFeline
GM-Tg-cang-SE0553-Ab-1/ GM-Tg-cang-SE0553-Ab-2Anti-Canine WFDC9 monoclonal antibodyCanine
GM-Tg-bovg-SE0553-Ab-1/ GM-Tg-bovg-SE0553-Ab-2Anti-Bovine WFDC9 monoclonal antibodyBovine
GM-Tg-equg-SE0553-Ab-1/ GM-Tg-equg-SE0553-Ab-2Anti-Equine WFDC9 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0553-Ab-1/ GM-Tg-hg-SE0553-Ab-2; GM-Tg-rg-SE0553-Ab-1/ GM-Tg-rg-SE0553-Ab-2;
GM-Tg-mg-SE0553-Ab-1/ GM-Tg-mg-SE0553-Ab-2; GM-Tg-cynog-SE0553-Ab-1/ GM-Tg-cynog-SE0553-Ab-2;
GM-Tg-felg-SE0553-Ab-1/ GM-Tg-felg-SE0553-Ab-2; GM-Tg-cang-SE0553-Ab-1/ GM-Tg-cang-SE0553-Ab-2;
GM-Tg-bovg-SE0553-Ab-1/ GM-Tg-bovg-SE0553-Ab-2; GM-Tg-equg-SE0553-Ab-1/ GM-Tg-equg-SE0553-Ab-2
Products NameAnti-WFDC9 monoclonal antibody
Formatmab
Target NameWFDC9
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-WFDC9 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0553-Ag-1Recombinant multi-species WFDC9/ WAP9/ dJ688G8.2 protein


    Target information

    Target IDGM-SE0553
    Target NameWFDC9
    Gene ID259240,629754,714926,119865551,109497975,101904236,100630200
    Gene Symbol and SynonymsdJ688G8.2,WAP9,WFDC9
    Uniprot AccessionQ8NEX5
    Uniprot Entry NameWFDC9_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000180205
    Target ClassificationN/A

    The target: WFDC9, gene name: WFDC9, also named as WAP9, dJ688G8.2. The WAP-type four-disulfide core (WFDC) domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor in many members of the WFDC domain family. This gene encodes a protein which contains a WFDC domain, and is thus a member of the WFDC domain family. This gene and several other gene family members are clustered at 20q13.12. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.